Disability Improvements With Ublituximab in Relapsing Multiple Sclerosis: Pooled Post Hoc Analyses of the ULTIMATE I and II Studies

Drug Category : Array
Conference Category : Array
Lead Author : Cree B, et al.
Published Date : 27/06/2022
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2022/06/Disability-Improvement_EAN-2022_Pos-LO_15June22e.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top